David Tesař

462 total citations
27 papers, 348 citations indexed

About

David Tesař is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, David Tesař has authored 27 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in David Tesař's work include Coronary Interventions and Diagnostics (10 papers), Lipoproteins and Cardiovascular Health (7 papers) and Cardiomyopathy and Myosin Studies (6 papers). David Tesař is often cited by papers focused on Coronary Interventions and Diagnostics (10 papers), Lipoproteins and Cardiovascular Health (7 papers) and Cardiomyopathy and Myosin Studies (6 papers). David Tesař collaborates with scholars based in Czechia, United States and Poland. David Tesař's co-authors include Josef Veselka, Josef Veselka, David Zemánek, T Honĕk, Martin Malý, Petr Hájek, Radka Adlová, Pavel Červinka, Paul Sorajja and Pavol Tomašov and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and International Journal of Cardiology.

In The Last Decade

David Tesař

26 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Tesař Czechia 12 274 143 69 50 35 27 348
Jean‐Philippe Metzger France 9 231 0.8× 135 0.9× 72 1.0× 48 1.0× 95 2.7× 16 321
Çetin Geçmen Türkiye 9 236 0.9× 86 0.6× 95 1.4× 30 0.6× 22 0.6× 41 281
Ricardo D’Oliveira Vieira Brazil 7 191 0.7× 188 1.3× 64 0.9× 46 0.9× 21 0.6× 13 276
Hirotomo Sato Japan 9 296 1.1× 110 0.8× 105 1.5× 164 3.3× 71 2.0× 37 345
P Sommer Germany 9 229 0.8× 43 0.3× 28 0.4× 25 0.5× 46 1.3× 27 303
Özkan Candan Türkiye 11 315 1.1× 108 0.8× 123 1.8× 55 1.1× 25 0.7× 48 356
Shigeru Amitani Japan 7 352 1.3× 58 0.4× 28 0.4× 33 0.7× 41 1.2× 17 396
Mihail Spînu Romania 10 137 0.5× 209 1.5× 76 1.1× 32 0.6× 95 2.7× 30 306
Enrico Vizzardi Italy 10 224 0.8× 123 0.9× 45 0.7× 75 1.5× 56 1.6× 17 282
Vincenzo Paravati Italy 8 196 0.7× 81 0.6× 53 0.8× 18 0.4× 106 3.0× 21 254

Countries citing papers authored by David Tesař

Since Specialization
Citations

This map shows the geographic impact of David Tesař's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tesař with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tesař more than expected).

Fields of papers citing papers by David Tesař

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tesař. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tesař. The network helps show where David Tesař may publish in the future.

Co-authorship network of co-authors of David Tesař

This figure shows the co-authorship network connecting the top 25 collaborators of David Tesař. A scholar is included among the top collaborators of David Tesař based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tesař. David Tesař is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kala, Petr, David Tesař, Petr Hájek, Radka Adlová, & Josef Veselka. (2020). Combined percutaneous approach for aortic valve implantation in poor vascular access. Bratislavské lekárske listy/Bratislava medical journal. 121(8). 537–540. 1 indexed citations
2.
3.
Veselka, Josef, Petr Hájek, Pavol Tomašov, et al.. (2013). Effect of Rosuvastatin Therapy on Troponin I Release Following Percutaneous Coronary Intervention in Nonemergency Patients (from the TIP 3 Study). The American Journal of Cardiology. 113(3). 446–451. 7 indexed citations
4.
Veselka, Josef, Pavol Tomašov, Petr Hájek, et al.. (2012). Comparison of mid-term outcomes of carotid artery stenting for moderate versus critical stenosis. Archives of Medical Science. 1(1). 75–80. 5 indexed citations
5.
Veselka, Josef, Petr Hájek, Martin Malý, et al.. (2011). COMPARISON OF MID-TERM OUTCOMES OF CAROTID ARTERY STENTING FOR MODERATE VERSUS CRITICAL STENOSIS. Journal of the American College of Cardiology. 57(14). E1956–E1956. 1 indexed citations
6.
Veselka, Josef, David Zemánek, Petr Hájek, et al.. (2011). Effect of Two-Day Atorvastatin Pretreatment on Long-Term Outcome of Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention. The American Journal of Cardiology. 107(9). 1295–1299. 15 indexed citations
7.
Veselka, Josef, Petr Hájek, Martin Malý, et al.. (2011). Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins. Archives of Medical Science. 1(1). 67–72. 8 indexed citations
8.
Veselka, Josef, et al.. (2009). Complications of low‐dose, echo‐guided alcohol septal ablation. Catheterization and Cardiovascular Interventions. 75(4). 546–550. 13 indexed citations
9.
Veselka, Josef, David Zemánek, Petr Hájek, et al.. (2009). Effect of Two-Day Atorvastatin Pretreatment on the Incidence of Periprocedural Myocardial Infarction Following Elective Percutaneous Coronary Intervention: A Single-Center, Prospective, and Randomized Study. The American Journal of Cardiology. 104(5). 630–633. 31 indexed citations
10.
Malý, Martin, Iuri Marinov, Petr Hájek, et al.. (2009). Subacute stent thrombosis associated with high residual platelet activity. Cor et Vasa. 51(11-12). 817–820.
12.
Veselka, Josef, et al.. (2006). Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention. Heart and Vessels. 21(3). 146–151. 22 indexed citations
13.
14.
Zemánek, David, et al.. (2005). The anomalous origin of the left coronary artery from the right aortic sinus: is the coronary angiography still a ‘gold standard’?. International journal of cardiac imaging. 22(2). 127–133. 11 indexed citations
15.
Veselka, Josef, et al.. (2005). Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes. The American Journal of Cardiology. 95(5). 675–678. 46 indexed citations
16.
Veselka, Josef, et al.. (2004). Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Catheterization and Cardiovascular Interventions. 63(2). 231–235. 37 indexed citations
17.
Veselka, Josef, David Tesař, T Honĕk, & Jan Burkert. (2003). Treatment of recurrent coronary rupture by implantation of three coronary stent-grafts. PubMed. 5(2). 88–91. 4 indexed citations
19.
Veselka, Josef, et al.. (2000). Direct stenting without predilatation: a new approach to coronary intervention. Coronary Artery Disease. 11(6). 503–507. 10 indexed citations
20.
Triggs, William J., David Tesař, & Michael Young. (1998). Ipsilateral motor control in pathological left-handedness. Neurocase. 4(1). 65–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026